ZA846132B - Externalization of products of bacteria - Google Patents

Externalization of products of bacteria

Info

Publication number
ZA846132B
ZA846132B ZA846132A ZA846132A ZA846132B ZA 846132 B ZA846132 B ZA 846132B ZA 846132 A ZA846132 A ZA 846132A ZA 846132 A ZA846132 A ZA 846132A ZA 846132 B ZA846132 B ZA 846132B
Authority
ZA
South Africa
Prior art keywords
product
externalization
bacteria
products
temperature
Prior art date
Application number
ZA846132A
Other languages
English (en)
Inventor
Martin Rosengerg
Jeffrey Ira Auerbach
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA846132B publication Critical patent/ZA846132B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
ZA846132A 1983-08-09 1984-08-08 Externalization of products of bacteria ZA846132B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/521,517 US4637980A (en) 1983-08-09 1983-08-09 Externalization of products of bacteria

Publications (1)

Publication Number Publication Date
ZA846132B true ZA846132B (en) 1985-06-26

Family

ID=24077058

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA846132A ZA846132B (en) 1983-08-09 1984-08-08 Externalization of products of bacteria

Country Status (20)

Country Link
US (1) US4637980A (sv)
EP (1) EP0140864B1 (sv)
JP (3) JPH0698018B2 (sv)
KR (1) KR940004545B1 (sv)
AT (1) ATE51024T1 (sv)
AU (1) AU583014B2 (sv)
CA (1) CA1219825A (sv)
DE (1) DE3481629D1 (sv)
DK (1) DK172672B1 (sv)
ES (2) ES8602124A1 (sv)
FI (1) FI89507C (sv)
GR (1) GR80053B (sv)
HU (1) HU197940B (sv)
IE (1) IE57797B1 (sv)
IL (1) IL72623A (sv)
NO (1) NO169242C (sv)
NZ (1) NZ209128A (sv)
PT (1) PT79045A (sv)
ZA (1) ZA846132B (sv)
ZW (1) ZW12684A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894334A (en) * 1984-03-28 1990-01-16 Cetus Corporation Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US5162217A (en) * 1984-08-27 1992-11-10 Bio-Technology General Corp. Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
US5759816A (en) * 1984-08-27 1998-06-02 Bio-Technology General Corp. Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods
TW205070B (sv) * 1986-06-30 1993-05-01 Takeda Pharm Industry Co Ltd
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
DE4023721A1 (de) * 1990-07-26 1992-01-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von vakzinen und ihre verwendung
GB9223709D0 (en) * 1992-11-12 1992-12-23 Ici Plc Process for the separation of protein from microorganisms
US5468629A (en) * 1993-04-13 1995-11-21 Calhoun; Cornelia Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
AU1223600A (en) * 1998-10-28 2000-05-15 Genentech Inc. Process
EP1124941B1 (en) * 1998-10-28 2003-09-17 Genentech, Inc. Process for recovering heterologous polypeptides from bacterial cells
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
EP1309716A4 (en) * 2000-08-15 2005-08-03 Phage Biotechnology Corp METHOD FOR PRODUCING BIOLOGICALLY ACTIVE HUMAN AZIDES FIBROBLAST GROWTH FACTOR AND USE THEREOF FOR PROMOTING ANGIONESIS
CA2419203A1 (en) * 2000-08-15 2002-02-21 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
PL2336153T3 (pl) 2003-11-21 2016-08-31 Pfenex Inc Udoskonalone systemy ekspresji z układem wydzielania SEC
US20050214321A1 (en) * 2003-12-01 2005-09-29 Dow Global Technologies Inc. Recombinant icosahedral virus like particle production in pseudomonads
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
US7892811B2 (en) * 2004-08-17 2011-02-22 Zymo Research Corporation Controlled lysis of bacteria
CA2677179C (en) 2007-01-31 2016-02-16 Dow Global Technologies Inc. Bacterial leader sequences for increased expression
EP2142651B1 (en) 2007-04-27 2013-05-22 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
WO2009025690A2 (en) 2007-05-23 2009-02-26 Nature Technology Corporation Improved e. coli plasmid dna production
US8318481B2 (en) * 2007-12-07 2012-11-27 Pfenex Inc. High copy number self-replicating plasmids in pseudomonas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
EP0061250A3 (en) * 1981-03-23 1983-09-28 Biogen N.V. Improved process for recovering products produced by host organisms
CA1185197A (en) * 1981-04-30 1985-04-09 Akira Furuya Lysozyme-sensitive microorganism
EP0074808A3 (en) * 1981-09-16 1984-07-04 University Patents, Inc. Recombinant method and materials

Also Published As

Publication number Publication date
NO169242C (no) 1992-05-27
ATE51024T1 (de) 1990-03-15
IE842021L (en) 1985-02-09
JPH0714348B2 (ja) 1995-02-22
ZW12684A1 (en) 1984-11-21
HU197940B (en) 1989-06-28
DK380684D0 (da) 1984-08-07
DE3481629D1 (de) 1990-04-19
FI89507C (sv) 1993-10-11
EP0140864B1 (en) 1990-03-14
CA1219825A (en) 1987-03-31
FI89507B (fi) 1993-06-30
NZ209128A (en) 1990-06-26
AU583014B2 (en) 1989-04-20
AU3163884A (en) 1985-02-14
JPH0698018B2 (ja) 1994-12-07
NO843183L (no) 1985-02-11
ES534963A0 (es) 1985-11-01
EP0140864A1 (en) 1985-05-08
JPH0787787B2 (ja) 1995-09-27
KR940004545B1 (ko) 1994-05-25
GR80053B (en) 1984-12-12
FI843104A (fi) 1985-02-10
NO169242B (no) 1992-02-17
US4637980A (en) 1987-01-20
DK172672B1 (da) 1999-05-10
ES8703524A1 (es) 1987-02-16
JPS6062985A (ja) 1985-04-11
IL72623A0 (en) 1984-11-30
IL72623A (en) 1990-04-29
DK380684A (da) 1985-02-10
FI843104A0 (fi) 1984-08-07
ES8602124A1 (es) 1985-11-01
KR850001530A (ko) 1985-03-30
PT79045A (en) 1984-09-01
ES543207A0 (es) 1987-02-16
IE57797B1 (en) 1993-04-07
JPH06121691A (ja) 1994-05-06
JPH07115974A (ja) 1995-05-09
HUT35010A (en) 1985-05-28

Similar Documents

Publication Publication Date Title
ZA846132B (en) Externalization of products of bacteria
DE69016012D1 (en) Neue hyperthermostabile alpha - amylase.
EP0332369A3 (en) Antibiotic
GB2184334B (en) A process for the production of lyophilized kefir yoghurt,and health food containing the same as main ingredient
IE851337L (en) Cell surface protein
AU588793B2 (en) Method of expressing alpha-1-antitrypsin in bacteria
EP0362209A4 (en) NEW SYNTHETIC BIOACTIVE COMPOUNDS AND METHOD FOR PRODUCING BIOACTIVE EFFECTS.
GB2152509B (en) Process for the production of l-lysine by fermentation and microorganisms for use therein
ZA892325B (en) Protease-deficient gram-positive bacteria and their use as host organisms for the production of recombinant products
JO1344B1 (en) The process of extracting bacteria products
DE3167109D1 (en) Sucrose-mutase, immobilized sucrose-mutase and use of this immobilized sucrose-mutase for the production of isomaltulose(6-o-alpha-d-glucopyranosido-d fructose)
MD950374A (ro) Procedeu de fabricare a zahărului şi utilizarea antibioticelor de tip polieter ionofor
CS592184A2 (en) Method of biologically active substance production with immunostimulating effect
GB1413224A (en) Purifying 1,4-dicyanobutenes
TW241305B (sv)
MY102317A (en) Novel microorganisms and a method for production of glutamic acid using the same.
EP0413615A3 (en) Process for the protection and conservation of micro-organisms, particularly of bacteria
MX9602206A (es) Cultivo bacteriano y procedimiento para oxidar un sulfuro o porcion del mismo a azufre elemental.
TH2343EX (th) กรรมวิธีการทำให้จุลินทรีย์ปล่อยผลิตภัณฑ์ออกมานอกเซล
RO100410A2 (ro) Procedeu de obtinere a portelanului negru
ES8706820A1 (es) Procedimiento para el cultivo submerso de cepas de bacteriaspseudomonas aeruginosa de la familia taxonomica pseudomona- daceae
ES8701687A1 (es) Mejoras introducidas en los procesos de obtencion de metabi-sulfito sodico
PH23346A (en) Process for controlling bacterial wilt by using root-colonizing bacteria